All In Biotech

Drug Trial Radar · NCT07157787

Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)

A Phase 2a, Randomized, Double-blind, Placebo-controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of ALXN1920 in Adult Participants With PMN (Primary Membranous Nephropathy) Who Are at a High Risk for Disease Progression

Last checked: Nov 20, 2026Latest source record: Jun 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Sep 19, 2025

Primary completion

Jul 2, 2027

Study completion Jul 9, 2027

Sponsor

Lead sponsor
Alexion Pharmaceuticals, Inc.AstraZeneca (AZN)
Sponsor type
Industry
Collaborators
AstraZeneca
First posted
Sep 5, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to evaluate the efficacy of ALXN1920 compared with placebo in participants with PMN who are at a high risk for disease progression using 24-hour urine protein creatinine ratio (UPCR).

Conditions

  • Primary Membranous Nephropathy

Interventions

  • ALXN1920Drug

    Participants will receive ALXN1920 SC infusion.

  • PlaceboDrug

    Participants will receive Placebo SC infusion.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Proteinuria Based on 24-hour UPCR at Week 26Time frame: Baseline, Week 26

Locations

40 sites in 10 countries. Site status is shown where the registry gives one.

  • Research Site

    Loma Linda, California · Recruiting

  • Research Site

    San Diego, California · Recruiting

  • Research Site

    Minneapolis, Minnesota · Recruiting

  • Research Site

    Rochester, Minnesota · Recruiting

  • Research Site

    Houston, Texas · Recruiting

  • Research Site

    Buenos Aires, Argentina · Recruiting

  • Research Site

    CABA, Argentina · Recruiting

  • Research Site

    Ciudad de Buenos Aires, Argentina · Recruiting

  • Research Site

    La Plata, Argentina · Not yet recruiting

  • Research Site

    Rosario, Argentina · Recruiting

  • Research Site

    Santa Fe, Argentina · Withdrawn

  • Research Site

    Santa Fe, Argentina · Withdrawn

  • Research Site

    Gosford, Australia · Active not recruiting

  • Research Site

    Parkville, Australia · Recruiting

  • Research Site

    Southport, Australia · Recruiting

  • Research Site

    Recife, Brazil · Recruiting

  • Research Site

    Salvador, Brazil · Recruiting

  • Research Site

    São Paulo, Brazil · Recruiting

  • Research Site

    São Paulo, Brazil · Recruiting

  • Research Site

    Baotou, China · Recruiting

  • Research Site

    Beijing, China · Recruiting

  • Research Site

    Guangzhou, China · Recruiting

  • Research Site

    Shenzhen, China · Recruiting

  • Research Site

    Créteil, France · Withdrawn

  • Research Site

    Nice, France · Recruiting

  • Research Site

    Toulouse, France · Recruiting

  • Research Site

    Milan, Italy · Recruiting

  • Research Site

    Ranica, Italy · Recruiting

  • Research Site

    Torrette, Italy · Recruiting

  • Research Site

    Barcelona, Spain · Recruiting

  • Research Site

    Madrid, Spain · Recruiting

  • Research Site

    Seville, Spain · Recruiting

  • Research Site

    Toledo, Spain · Recruiting

  • Research Site

    Kaohsiung City, Taiwan · Recruiting

  • Research Site

    Taichung, Taiwan · Recruiting

  • Research Site

    Taoyuan, Taiwan · Recruiting

  • Research Site

    Cambridge, United Kingdom · Recruiting

  • Research Site

    Leicester, United Kingdom · Recruiting

  • Research Site

    London, United Kingdom · Recruiting

  • Research Site

    Salford, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.